KARI 101
KARI 101 is a blood-brain barrier permeable acid sphingomyelinase (ASM) inhibitor. KARI 101 directly inhibits ASM activity and reduces ceramide production. KARI 101 induces Ca2+ mobilization, activates AMPK and triggers GHSR1α internalization. KARI 101 can be used for the research of Alzheimer's disease.
For research use only. We do not sell to patients.
- CAS No.: 3061559-97-2
- Formula: C15H30N4O2
- Molecular Weight:298.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
KARI 101 binds to purified acid sphingomyelinase (ASM) protein with high affinity[1].
KARI 101 inhibits the activity of secretory acid sphingomyelinase (ASM) in the supernatant of fibroblasts from PS1 familial Alzheimer's disease[1].
KARI 101 acts as a potent GHSR1α agonist in HEK293A cells overexpressing GHSR1α, with an EC50 of 188.5 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3061559-97-2
-
Molecular Weight 298.42
-
Formula C15H30N4O2
-
SMILES
OCC(C1=CN(CCCCCCCCCC)N=N1)(CO)N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- KARI 101
- 3061559-97-2
- KARI101
- KARI-101
- Phosphatase
- AMPK
- Calcium Channel
- GHSR
- AMP-activated protein kinase
- Ca2+ channels
- Ca channels
- Growth hormone secretagogue receptor
- Ghrelin receptor
- ghrelin receptor
- ceramide
- acid sphingomyelinase
- blood-brain barrier
- growth hormone secretagogue receptor 1α
- alzheimer's disease
- SMPD1 mRNA
- PS1-familial Alzheimer's disease patient fibroblasts
- HEK293A cells
- Inhibitor
- inhibitor
- inhibit